Menu

Ancient Fish Analyzed

Two paleontological findings yield insights into early vertebrate evolution.

Jun 13, 2014
Rina Shaikh-Lesko

An artist's rendering of MetasprigginaMARIANNE COLLINS © CONWAY MORRIS AND CARONMetaspriggina, was described in Nature this week (June 11). Until now, researchers’ knowledge of the fish was based on incomplete fossils. A team led by Jean-Bernard Caron of the Royal Ontario Museum found an unexpectedly rich deposit of fossils—including 40 Metaspriggina—in the Burgess Shale, the famed fossil field in the Canadian Rockies, in 2012. Caron invited Simon Conway Morris of the University of Cambridge, a leading expert on the extinct animal, to collaborate. The team’s fossil analysis revealed that the fish had several vertebrate features, including a notochord, camera-like eyes, paired nasal sacs, what appeared to be a cranium, and similar muscle structure similar to modern fish.

“It’s clearly a benchmark early vertebrate, which we haven’t had before,” Thurston Lacalli of the University of Victoria in British Columbia, who was not involved in the research, told The New York Times.

Over in Scientific Reports, a team led by You’an Zhu of the Chinese Academy of Sciences this week (June 12) reported on a fossil of an early jawed fish that’s approximately 423 million years old. The large fish, Megamastax, appears to have used its strong jaws to crack open smaller, shelled fish.

“By sheer size alone, it could have eaten just about anything it wanted, although its teeth suggest it had a preference for hard-shelled prey,” coauthor Brian Choo told New Scientist. “Clearly there is an early history of jawed vertebrates that extends much further back in time that we currently know very little of,” he added.

January 2019

Cannabis on Board

Research suggests ill effects of cannabinoids in the womb

Marketplace

Sponsored Product Updates

FORMULATRIX® digital PCR technology to be acquired by QIAGEN
FORMULATRIX® digital PCR technology to be acquired by QIAGEN
FORMULATRIX has announced that their digital PCR assets, including the CONSTELLATION® series of instruments, is being acquired by QIAGEN N.V. (NYSE: QGEN, Frankfurt Stock Exchange: QIA) for up to $260 million ($125 million upfront payment and $135 million of milestones).  QIAGEN has announced plans for a global launch in 2020 of a new series of digital PCR platforms that utilize the advanced dPCR technology developed by FORMULATRIX combined with QIAGEN’s expertise in assay development and automation.
Application of CRISPR/Cas to the Generation of Genetically Engineered Mice
Application of CRISPR/Cas to the Generation of Genetically Engineered Mice
With this application note from Taconic, learn about the power that the CRISPR/Cas system has to revolutionize the field of custom mouse model generation!
Translational Models of Obesity, Dysmetabolism, Diabetes, and Complications
Translational Models of Obesity, Dysmetabolism, Diabetes, and Complications
This webinar, from Crown Bioscience, presents a unique continuum of translational dysmetabolic platforms that more closely mimic human disease. Learn about using next-generation rodent and spontaneously diabetic non-human primate models to accurately model human-relevant disease progression and complications related to obesity and diabetes here!
BiochemAR: an augmented reality app for easy visualization of virtual 3D molecular models
BiochemAR: an augmented reality app for easy visualization of virtual 3D molecular models
Have you played Pokemon Go? Then you've used Augmented Reality (AR) technology! AR technology holds substantial promise and potential for providing a low-cost, easy to use digital platform for the manipulation of virtual 3D objects, including 3D models of biological macromolecules.